Summit Therapeutics Inc

NASDAQ:SMMT

3.23

-0.27 (-7.71%)

7:59:31 PM EDT: $3.24 +0.01 (+0.31%)

Summit Therapeutics Inc Stock, NASDAQ:SMMT

2882 Sand Hill Road, Suite 106, Menlo Park, California 94025

United States of America

Phone: +1.617.514.7149

Number of Employees: 110

http://www.summittxinc.com

Description

Summit Therapeutics, Inc. a biopharmaceutical company, which discovers, develops, and commercializes medicines to treat infectious diseases. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Menlo Park, CA.